IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Anthem Biosciences IPO listing price is ₹ 723.05, issue price is ₹ 570.00, and currently trading at ₹ 749.65 as on August 7, 2025. Anthem Biosciences IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Anthem Biosciences IPO is a Book Building listing on BSE,NSE exchange. The company is based in Bangalore and caters to Pharmaceutical sector. Citigroup Global Markets India , J.P. Morgan India , Jm Financial , Nomura Financial Advisory And Securities (India) are the merchant bankers of Anthem Biosciences IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st December 2024.
Anthem Biosciences IPO offer price is ₹ 570.00 and got listed at ₹ 723.05. Read Anthem Biosciences IPO details mentioned above.The IPO of Anthem Biosciences Limited was listed on 21st July 2025. As of today, Anthem Biosciences IPO is trading at ₹ 749.65, compared to the previous day’s close of ₹ 724.50. Read the report above for detailed IPO performance.
The issue price of Anthem Biosciences IPO was ₹ 570.00 per equity share.
Anthem Biosciences IPO was listed at ₹723.05 on the stock exchange on 21st July 2025. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of August 7, 2025, the current market price of Anthem Biosciences IPO is ₹ 749.65.
The 52-week high for Anthem Biosciences IPO is ₹ 801.85, while the 52-week low is ₹ 701.90. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Anthem Biosciences IPO listed at ₹ 723.05 against the issue price of ₹ 570.00 per equity share, showing a listing day gain/loss of 153.05 (26.85%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Anthem Biosciences IPO stock moved from its listing price of ₹ 723.05 to the current price of ₹749.65 per equity share, reflecting a change of 3.68% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Anthem Biosciences IPO issue date of 21st July 2025 and CMP of ₹749.65, the estimated CAGR is approximately 25765.73%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 2
Issue
Price :
₹ 570.00
Listing Price :
₹ 723.05
Previous Day Closing
₹ 724.50
Anthem Biosciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Anthem Biosciences Financial Review Page
Merchant Banker(s) of Anthem Biosciences IPO: Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Jm Financial Limited , Nomura Financial Advisory And Securities (India) Private Limited
Anthem Biosciences IPO subscription was 67.42 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Anthem Biosciences IPO listed at a listing price of 723.05 against the offer price of 570.00.
The current market price of Anthem Biosciences is 749.65.
Why Us?
